UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049677
Receipt number R000056563
Scientific Title Investigation of infertility treatment outcomes in patients with premature ovarian insufficiency
Date of disclosure of the study information 2022/12/05
Last modified on 2022/12/02 19:47:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of infertility treatment outcomes in patients with premature ovarian insufficiency

Acronym

Investigation of infertility treatment outcomes in patients with premature ovarian insufficiency

Scientific Title

Investigation of infertility treatment outcomes in patients with premature ovarian insufficiency

Scientific Title:Acronym

Investigation of infertility treatment outcomes in patients with premature ovarian insufficiency

Region

Japan


Condition

Condition

Premature ovarian insufficiency

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In assisted reproductive medicine, anti-mullerian hormone (AMH) is widely used as an indicator of ovarian reserve. Although a woman's age is the most important factor affecting fertility outcomes, there have been reports suggesting a correlation with AMH levels in cases of premature ovarian insufficiency(POI). The purpose of this study is to estimate the factors that contribute to the failure to achieve pregnancy in patients with POI by accumulating cases of POI and comparing the results of infertility treatment according to the cause of the POI.

Basic objectives2

Others

Basic objectives -Others

The study design is a retrospective multi-institutional, observational study, in which data will be collected on patients who underwent their first IVF/ICSI procedure between January 1, 2021 and December 31, 2021, and who had AMH less than 1.1 ng/mL.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Clinical pregnancy rate per IVF/ICSI treatment cycle by cause of POI

Key secondary outcomes

Type of fertility drugs, dosage, number of eggs retrieved, number of fertilized eggs, number of embryos transferred, embryo grade, production rate


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >=

Gender

Female

Key inclusion criteria

1) Patients who started their first IVF/ICSI treatment cycle between January 1, 2021 and December 31, 2021.(The start date of the treatment cycle is the start date of regulated ovarian stimulation, or the start date of menstruation in the case of natural cycles.)
2) Patients whose AMH concentration is less than 1.1 ng/mL within 6 months prior to IVF/ICSI treatment.

Key exclusion criteria

Patients who are deemed inappropriate for inclusion in the program by a physician's judgment

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Akira
Middle name
Last name Iwase

Organization

Gunma university hospital

Division name

Department of Obstetrics & Gynecology

Zip code

371-8511

Address

3-39-15 Showa-machi, Maebashi, Gunma

TEL

027-220-8429

Email

akiwase@gunma-u.ac.jp


Public contact

Name of contact person

1st name Akira
Middle name
Last name Iwase

Organization

Department of Gunma university hospital

Division name

Obstetrics & Gynecology

Zip code

371-8511

Address

3-39-15 Showa-machi, Maebashi, Gunma

TEL

027-220-8429

Homepage URL


Email

akiwase@gunma-u.ac.jp


Sponsor or person

Institute

Gunma university hospital

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Akita University Graduate School of Medicine ,Department of Obstetrics and Gynecology
Asada Ladies Clinic
Kansai Medical University Hospital, Department of Obstetrics and Gynecology
Keio University School of Medicine ,Department of Obstetrics and Gynecology
Saitama Medical School Hospital ,Department of Obstetrics and Gynecology
Saitama Medical School General Medical Center ,Department of Obstetrics and Gynecology
Jichi Medical University ,Department of Obstetrics and Gynecology
Shimane University School of Medicine Center for Comprehensive Perinatal Maternal and Child Health Care
Sugiyama Obstetrics and Gynecology Clinic
St. Marianna University School of Medicine ,Department of Obstetrics and Gynecology
Tokyo Medical University ,Department of Obstetrics and Gynecology
The University of Tokyo Hospital ,Department of Women's Medicine and Surgery
Toho University Medical Center Omori Hospital ,Department of Obstetrics and Gynecology
Tokushima University Hospital ,Department of Obstetrics and Gynecology
Nagasaki University Hospital ,Department of Obstetrics and Gynecology
Hyogo University of Medical Science ,Department of Obstetrics and Gynecology

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gunma university

Address

3-39-15 Showa-machi, Maebashi, Gunma

Tel

027-220-8763

Email

hitotaisho-ciru@ml.gunma-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 05 Day


Related information

URL releasing protocol

https://ciru.dept.showa.gunma-u.ac.jp/guidance/storage-sample/pdf/IRB2022-034.pdf

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 09 Month 15 Day

Date of IRB

2022 Year 09 Month 30 Day

Anticipated trial start date

2022 Year 11 Month 01 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

https://ciru.dept.showa.gunma-u.ac.jp/guidance/storage-sample/pdf/IRB2022-034.pdf


Management information

Registered date

2022 Year 12 Month 02 Day

Last modified on

2022 Year 12 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056563